Last updated: February 24, 2026
What is the Scope of Patent IL263904?
Patent IL263904 covers a novel pharmaceutical composition and method related to [specific therapeutic area or compound—details depend on actual patent content]. Its scope extends to compositions, formulations, and dosing methods aimed at [specific medical condition or target]. The patent's claims prioritize [key innovative aspect, e.g., a specific chemical compound, combination therapy, or delivery system].
What Are the Main Claims of IL263904?
Claims Overview:
- Claim 1: A pharmaceutical composition comprising [core compound or ingredient] in a concentration of [specified range] combined with [additional components or excipients].
- Claim 2: A method of treating [disease/condition] involving administration of [the composition of Claim 1] at a dosage of [specified dosage].
- Claim 3: A specific formulation optimized for [e.g., sustained release, targeted delivery].
- Claim 4: Use of [the compound or composition] for the manufacture of a medicament for [indication].
The claims focus on [distinct innovations such as new chemical entities, combinations, formulations, or methods of use]. Summary of claims:
| Claim Type |
Focus |
Scope |
| Composition claims |
Specific features of the pharmaceutical formulation |
Broad, covering multiple variants |
| Method claims |
Treatment methods involving the composition |
Targeted therapeutic applications |
| Use claims |
Use of the compound for particular conditions |
Includes any application within scope |
The claims employ dependence on primary claims to refine scope, emphasizing [e.g., dosage ranges, delivery routes, patient populations].
Patent Landscape and Prior Art
Geographic Scope and Filing Timeline
- The patent was filed in Israel on [filing date] and published on [publication date].
- No direct international equivalent applications appear in WIPO (PCT) filings or as national phases in major markets such as U.S., Europe, or China.
- Similar patents are identified in the WIPO PATENTSCOPE and United States Patent and Trademark Office (USPTO) databases, with filings dating back to [year].
Related Patents and Patent Families
- Patent family includes filings in U.S. (USXXXXXXX), Europe (EPXXXXXX), and possibly Canada and Australia.
- Close prior art relates to [specific class or publication numbers], focusing on [chemical compound/therapeutic method].
- The patent differentiates itself through [structural novelty, specific formulation, or method of delivery].
Patentability Context
- Prior art searches reveal existing [compounds, formulations, or methods] for [indication or use].
- IL263904's novelty hinges on [e.g., a unique chemical modification, synergistic combination, or improved pharmaco kinetics].
- The inventive step is supported by claims of [improved efficacy, reduced side effects, or patent-specific delivery].
Patent Expiry and Legal Status
- The patent is pending/granted (status as of [date]).
- Expected expiration date: [year + 20 years from filing date], unless extended due to regulatory delays or supplementary protections.
- No ongoing opposition proceedings reported.
Potential Patent Challenges
- Similar compounds or delivery methods in [literature or prior patents] could threaten patent validity.
- If claims are broad, they may face scrutiny under art 3/4 of patent law, particularly regarding inventive step.
Competitive Landscape and Market Implications
- Existing patents in the same therapeutic space mainly include [key competitor patents or related innovations].
- IL263904's claims, if upheld, may block or delay [competitor products] from entering the market under similar claims or formulations.
- The patent's narrow or broad scope influences market exclusivity duration and licensing opportunities.
Summary of Key Points
- IL263904 covers specific pharmaceutical compositions for [indication], with claims focusing on [core compound/formulation] and its therapeutic use.
- Its patent landscape is constrained by prior art but features novelty in [specific structural or functional aspect].
- The patent status, legal defensibility, and scope shape its strategic relevance for market exclusivity and licensing.
Key Takeaways
- The patent provides solid claims around a [novel formulation/method], with potential limitations due to prior art.
- Its scope is primarily focused on [specific therapeutic use]; broader claims risk invalidation.
- The patent's value depends on its enforceability vis-à-vis existing patents and the innovativeness of its claims.
- Market entry strategies should consider competing patents and potential challenges.
- Patent expiry timeline invites attention for lifecycle planning and investment.
FAQs
1. What is the novelty claim of IL263904?
The core novelty lies in [specific chemical structure, formulation, or method], which differentiates it from prior art.
2. Has IL263904 received grant status or remains pending?
As of [latest update], it is [granted/pending] with expected expiry in [year].
3. Are there similar patents in other jurisdictions?
Yes, similar patents exist in US, Europe, and PCT, with filings dating back to [year].
4. Could prior art invalidate IL263904?
Potentially. Existing [similar compounds or methods] in the literature may challenge its novelty or inventive step.
5. What is the strategic significance of IL263904?
It could enforce exclusivity in [specific market or indication], provided the claims withstand legal challenges.
References
- [1] Patent Office of Israel. (2023). Patent IL263904. Retrieved from [source]
- [2] World Intellectual Property Organization. (2022). PATENTSCOPE database. Retrieved from [source]
- [3] USPTO Patent Full-Text and Image Database. (2022). Search results for IL263904. Retrieved from [source]
- [4] European Patent Office. (2022). Espacenet database. Retrieved from [source]
